Alzheimer's drug that slows disease gets FDA backing

A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease.

Related Keywords

Japan ,Japanese ,Tanya Simuni ,Eli Lilly ,Thomas Montine ,National Institutes Of Health ,Northwestern University ,Stanford University ,Drug Administration ,Dean Follmann ,National Institutes ,